Breast Cancer Clinical Trial

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

Summary

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years of age or older
Ability to give informed consent
Stage I-III breast malignancy

Exclusion Criteria:

Unable to tolerate venipuncture

Study is for people with:

Breast Cancer

Estimated Enrollment:

99

Study ID:

NCT04022616

Recruitment Status:

Recruiting

Sponsor:

Ohio State University Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Ohio State University Comprehensive Cancer Center
Columbus Ohio, 43210, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

99

Study ID:

NCT04022616

Recruitment Status:

Recruiting

Sponsor:


Ohio State University Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.